JPMorgan Chase & Co’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251 | Sell |
43
-2
| -4% | -$12 | ﹤0.01% | 5873 |
|
|
2025
Q1 | $362 | Sell |
45
-1
| -2% | -$8 | ﹤0.01% | 5857 |
|
|
2024
Q4 | $487 | Hold |
46
| – | – | ﹤0.01% | 5750 |
|
|
2024
Q3 | $592 | Buy |
46
+4
| +10% | +$51 | ﹤0.01% | 5715 |
|
|
2024
Q2 | $630 | Hold |
42
| – | – | ﹤0.01% | 5639 |
|
|
2024
Q1 | $1.18K | Hold |
42
| – | – | ﹤0.01% | 5618 |
|
|
2023
Q4 | $941 | Sell |
42
-3,772
| -99% | -$84.5K | ﹤0.01% | 5802 |
|
|
2023
Q3 | $79.3K | Sell |
3,814
-2,618
| -41% | -$54.5K | ﹤0.01% | 4740 |
|
|
2023
Q2 | $165K | Sell |
6,432
-3,033
| -32% | -$77.6K | ﹤0.01% | 4381 |
|
|
2023
Q1 | $263K | Buy |
9,465
+8,470
| +851% | +$235K | ﹤0.01% | 4168 |
|
|
2022
Q4 | $26K | Buy |
995
+877
| +743% | +$22.9K | ﹤0.01% | 4897 |
|
|
2022
Q3 | $3K | Buy |
118
+46
| +64% | +$1.17K | ﹤0.01% | 5269 |
|
|
2022
Q2 | $3K | Sell |
72
-3,211
| -98% | -$134K | ﹤0.01% | 5373 |
|
|
2022
Q1 | $180K | Buy |
3,283
+40
| +1% | +$2.19K | ﹤0.01% | 4498 |
|
|
2021
Q4 | $318K | Sell |
3,243
-161
| -5% | -$15.8K | ﹤0.01% | 4301 |
|
|
2021
Q3 | $861K | Sell |
3,404
-801
| -19% | -$203K | ﹤0.01% | 3697 |
|
|
2021
Q2 | $1.3M | Sell |
4,205
-8,342
| -66% | -$2.58M | ﹤0.01% | 3489 |
|
|
2021
Q1 | $8.26M | Buy |
+12,547
| New | +$8.26M | ﹤0.01% | 2289 |
|